Benzbromarone is not a hormone, but a uric acid-lowering drug for the treatment of gout, the mechanism of action of Benzbromarone is mainly to promote the excretion of uric acid, Benzbromarone can not be used in patients with renal insufficiency of moderate or higher degree and with urinary stones. In the application of benzbromarone at the same time should drink a lot of water, promote uric acid excretion, to prevent the generation of urinary stones. At present, benzbromarone is not the first-line drug for the treatment of gout, because benzbromarone still has side effects, especially increasing the burden on the kidneys. Currently febuxostat is more and more widely used, febuxostat has the advantages of fast effect, good efficacy and inhibition of uric acid production, which is better than benzbromarone.